Elevated remnant cholesterol and triglycerides are predictors of increased total mortality in a primary health care population of 327,347 patients

被引:0
作者
Engell, Anna Elise [1 ]
Bathum, Lise [1 ]
Siersma, Volkert [2 ,3 ]
Andersen, Christen Lykkegaard [2 ,3 ,5 ]
Lind, Bent Struer [1 ,2 ,3 ]
Jorgensen, Henrik Lovendahl [1 ,4 ]
机构
[1] Copenhagen Univ Hosp, Dept Clin Biochem, Hvidovre, Denmark
[2] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark
[3] Univ Copenhagen, Res Unit Gen Practice, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Clin Med, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark
[5] Rigshospitalet, Univ Hosp Copenhagen, Dept Haematol, Copenhagen, Denmark
关键词
Remnant cholesterol; Lipids; All-cause mortality; Lipid lowering treatment; ALL-CAUSE MORTALITY; DENSITY-LIPOPROTEIN CHOLESTEROL; LDL CHOLESTEROL; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; APO-B; SERUM-CHOLESTEROL; HEART-DISEASE; PLASMA-LIPIDS; RISK-FACTOR;
D O I
10.1186/s12944-025-02607-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundHyperlipidemia is a well-established risk factor for cardiovascular disease and mortality. Recently, remnant cholesterol has been introduced as an important risk factor. This study explores the association between levels of remnant cholesterol, compared to the traditional lipid parameters (total cholesterol, low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides), and all-cause mortality in a population from general practice. Additionally, the impact of lipid-lowering treatment was evaluated.MethodsObservational cohort study based on the first lipid panel measurement from 327,347 patients from general practice in the Capital Region of Denmark between 2001 and 2018. LDL-C was calculated using the Friedewald equation. Patients with diagnoses or medical treatments that affected lipid levels were excluded. Cox proportional hazards models with restricted cubic splines were used to evaluate the association between all-cause mortality and lipid levels.ResultsA total of 34,014 patients died during the study. In an analysis censoring individuals receiving lipid lowering treatment after the lipid measurement, remnant cholesterol increased all-cause mortality risk linearly, with a hazard ratio (HR) of 1.6 (95% CI: 1.4; 1.7) at 3 mmol/L compared to a reference level of 0.9 mmol/L. Total cholesterol showed a U-shaped relationship with all-cause mortality with a HR of 2.5 (95% CI: 2.3; 2.7) at 2.5 mmol/L and 1.7 (95% CI: 1.6; 1.9) at 9 mmol/L (reference level 5 mmol/L). LDL-C and non-HDL-C exhibited a very similar U-shaped pattern. HDL-C also showed a U-shaped curve with a HR of 1.7 (95% CI: 1.6; 1.9) at 0.5 mmol/L and 1.4 (95% CI: 1.3; 1.5) at 3.5 mmol/L (reference level 1 mmol/L). The mortality risk related to triglycerides increased with rising triglyceride level, with a HR of 1.5 (95% CI: 1.3; 1.6) at 4.5 mmol/L (reference level 2 mmol/L).ConclusionsIn this study, high levels of all the six lipids as well as low levels of total cholesterol, LDL-C, non-HDL-C and HDL-C were associated with higher all-cause mortality in a primary health care population. Further research is needed, to consider if the current lipid lowering guidelines are appropriate and if more focus on remnant cholesterol levels should be applied.
引用
收藏
页数:17
相关论文
共 61 条
[1]   Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders [J].
Akerblom, Jennifer L. ;
Costa, Rosann ;
Luchsinger, Jose A. ;
Manly, Jennifer J. ;
Tang, Ming-Xin ;
Lee, Joseph H. ;
Mayeux, Richard ;
Schupf, Nicole .
AGE AND AGEING, 2008, 37 (02) :207-213
[2]  
Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010, 10.1016/j.jacc.2019.03.009]
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]   VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins [J].
Balling, Mie ;
Afzal, Shoaib ;
Varbo, Anette ;
Langsted, Anne ;
Smith, George Davey ;
Nordestgaard, Borge G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (23) :2725-2735
[5]   Association of lipoprotein levels with mortality in subjects aged 50+without previous diabetes or cardiovascular disease: A population-based register study [J].
Bathum, Lise ;
Christensen, Rene Depont ;
Pedersen, Lars Engers ;
Pedersen, Palle Lyngsie ;
Larsen, John ;
Nexoe, Jorgen .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2013, 31 (03) :172-180
[6]   Remnant cholesterol as a risk factor for cardiovascular, cancer or other causes mortality: A competing risks analysis [J].
Bonfiglio, Caterina ;
Leone, Carla M. ;
Silveira, Liciana V. A. ;
Guerra, Rocco ;
Misciagna, Giovanni ;
Caruso, Maria G. ;
Bruno, Irene ;
Buongiorno, Claudia ;
Campanella, Angelo ;
Guerra, Vito M. B. ;
Notarnicola, Maria ;
Deflorio, Valentina ;
Franco, Isabella ;
Bianco, Antonella ;
Mirizzi, Antonella ;
Aballay, Laura R. ;
Cisternino, Anna M. ;
Sorino, Paolo ;
Pesole, Pasqua L. ;
Osella, Alberto R. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (11) :2093-2102
[7]   Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium [J].
Brunner, Fabian J. ;
Waldeyer, Christoph ;
Ojeda, Francisco ;
Salomaa, Veikko ;
Kee, Frank ;
Sans, Susana ;
Thorand, Barbara ;
Giampaoli, Simona ;
Brambilla, Paolo ;
Tunstall-Pedoe, Hugh ;
Moitry, Marie ;
Iacoviello, Licia ;
Veronesi, Giovanni ;
Grassi, Guido ;
Mathiesen, Ellisiv B. ;
Soderberg, Stefan ;
Linneberg, Allan ;
Brenner, Hermann ;
Amouyel, Philippe ;
Ferrieres, Jean ;
Tamosiunas, Abdonas ;
Nikitin, Yuriy P. ;
Drygas, Wojciech ;
Melander, Olle ;
Joeckel, Karl-Heinz ;
Leistner, David M. ;
Shaw, Jonathan E. ;
Panagiotakos, Demosthenes B. ;
Simons, Leon A. ;
Kavousi, Maryam ;
Vasan, Ramachandran S. ;
Dullaart, Robin P. F. ;
Wannamethee, S. Goya ;
Riserus, Ulf ;
Shea, Steven ;
de Lemos, James A. ;
Omland, Torbjorn ;
Kuulasmaa, Kari ;
Landmesser, Ulf ;
Blankenberg, Stefan ;
Zeller, T. ;
Lackner, K. ;
Wild, P. ;
Peters, A. ;
Meisinger, C. ;
Voelzke, H. ;
Doerr, M. ;
Nauck, M. ;
Schoettker, B. ;
Lorenz, T. .
LANCET, 2019, 394 (10215) :2173-2183
[8]   Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease [J].
Castaner, Olga ;
Pinto, Xavier ;
Subirana, Isaac ;
Amor, Antonio J. ;
Ros, Emilio ;
Hernaez, Alvaro ;
Angel Martinez-Gonzalez, Miguel ;
Corella, Dolores ;
Salas-Salvado, Jordi ;
Estruch, Ramon ;
Lapetra, Jose ;
Gomez-Gracia, Enrique ;
Alonso-Gomez, Angel M. ;
Fiol, Miquel ;
Serra-Majem, Lluis ;
Corbella, Emili ;
Benaiges, David ;
Sorli, Jose V. ;
Ruiz-Canela, Miguel ;
Babio, Nancy ;
Sierra, Lucas Tojal ;
Ortega, Emilio ;
Fito, Montserrat .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (23) :2712-2724
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]   The Innovative Potential of Statins in Cancer: New Targets for New Therapies [J].
Di Bello, Elisabetta ;
Zwergel, Clemens ;
Mai, Antonello ;
Valente, Sergio .
FRONTIERS IN CHEMISTRY, 2020, 8